<DOC>
	<DOCNO>NCT00698022</DOCNO>
	<brief_summary>This 28-day , single-center , double-blind , placebo-controlled inpatient study administration risperidone alone combination mifepristone healthy adult male volunteer determine average change absolute weight Day 28 compare baseline .</brief_summary>
	<brief_title>A 4-week Study Mifepristone Prevention Risperidone-induced Weight Gain Healthy Male Volunteers</brief_title>
	<detailed_description>This 28-day , single-center , double-blind , placebo-controlled inpatient study administration risperidone alone combination mifepristone healthy adult male volunteer . The primary study objective determine mean change absolute weight Day 28 compare baseline normal healthy male volunteer treat risperidone plus mifepristone risperidone alone . The secondary study objective determine mean percent change baseline body weight ; proportion subject gain le 5 % le 7 % baseline body treatment group .</detailed_description>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>BMI ≥ 18 ≤ 23 kg/m2 Able provide write informed consent Routine clinical laboratory test either within normal limit clinically meaningful outside normal limit AST , ALT , Tbili within normal limit screen Medical psychiatric history physical examination devoid significant finding would interfere participation interpretation result study Agree use barrier method birth control 28 day follow last dose study medication Have maintain stable weight least 6 month prior Screening Prior current history psychiatric disorder , include eat disorder anorexia nervosa , bulimia nervosa , bingeeating disorder Positive urine drug screen drug abuse ( include amphetamine , cannabinoids , barbiturate , cocaine , opiates , benzodiazepine ) unless prescribe physician Participation clinical investigation drug , biological investigational therapy within 30 day prior dose Have history allergic reaction either mifepristone risperidone Any clinically significant abnormality screen laboratory test QTc Bazzett 's ≥ 450 msec History current major medical condition , opinion Investigator would place patient undue risk . Receiving prescription overthecounter medication could potentially affect appetite weight Any history movement disorder Tardive Dyskinesia , Parkinsonism Any personal family history Neuroleptic Malignant Syndrome</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>healthy</keyword>
	<keyword>weight gain</keyword>
	<keyword>anti-psychotic</keyword>
	<keyword>risperidone</keyword>
	<keyword>mifepristone</keyword>
	<keyword>mitigation</keyword>
	<keyword>weight loss</keyword>
</DOC>